Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation

Gemcitabine (GCB) is a pyrimidine antimetabolite widely used in various solid tumors as a single agent or as a component of multidrug regimens. In the majority of patients, GCB is well tolerated, however life-threatening complications occasionally occur. The current report presents four cases of sev...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Lett
Asıl Yazarlar: Hryciuk, Beata, Szymanowski, Bartosz, Romanowska, Anna, Salt, Ewa, Wasąg, Bartosz, Grala, Bartłomiej, Jassem, Jacek, Duchnowska, Renata
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2018
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5774463/
https://ncbi.nlm.nih.gov/pubmed/29434889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7473
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller